Many celebrities are talking enthusiastically about their experiences with weight-loss drugs — especially semaglutide-based glucagon-like peptide 1 receptor agonists (GLP-1 RAs; Ozempic, Wegovy). It’s no surprise that the recent Golden Globes was dubbed “Ozempic’s biggest night.” That show exemplified the fervent celebrity chatter that has helped send prescriptions for these drugs skyrocketing. Comedian Tracy Morgan, … Read more
Diabetes is one of the most common chronic lifestyle conditions. Yet, it is incorrectly believed that diabetes is diagnosed only in those with a sweet tooth. Addressing the misconception, nutritionist Charmaine Ha Dominguez informed that type 2 diabetes is not necessarily caused by having too much sugar. “I hear this a lot from people who … Read more
GLP-1s for HFpEF: Better Outcomes With Patient-Centered Care Medscape Source link
More than a third of websites that advertise and sell compounded versions of popular drugs for diabetes and weight loss — such as Ozempic and Wegovy — falsely claim the compounded medications have been approved by the Food and Drug Administration (FDA), according to a recent research letter. Compounded drugs, such as those using the … Read more
Practiced for centuries as a ritual in many religions, intermittent fasting (IF) is rapidly growing in popularity as a weight loss and health-improvement tool. A 2024 survey found that as many as 13% of Americans followed an IF regimen during the previous year. But does it really offer health benefits? And are there any downsides? … Read more
We know now that glucagon-like peptide 1 (GLP-1) drugs for obesity bring with them a whole host of other potential benefits, as well as a handful of side effects. But new research has brought a sharper focus on both the pros and the cons of these medications, and with that comes new challenges and opportunities … Read more
As glucagon-like peptide 1 (GLP-1) receptor agonist use becomes more prevalent, patients are using them for new indications — and at new dosages. Say hello to microdosing, or taking doses lower than the recommended therapeutic amount, for various reasons: Weight maintenance, metabolic health improvements, anti-inflammation and anti-autoimmune effects, fewer side effects, and lower costs. Advocates … Read more
Consumption of sugary drinks is linked to 9.8% of new cases of type 2 diabetes (T2D) annually, contributing to approximately 2.2 million cases worldwide. These beverages are also linked to 1.2 million new cardiovascular disease (CVD) cases each year, or 3.1% of the global total, according to a study published in Nature Medicine. The researchers analyzed … Read more
Pharmacy Leaders Issue Fresh Warning Over Online Sale of Weight Loss Jabs The National Pharmacy Association (NPA) has issued a new warning against the online sale of weight loss jabs, calling for stricter regulations to safeguard patient safety. The association highlighted concerns that individuals with a history of eating disorders or those with already low … Read more
Physical inactivity increases the risk for diabetes, other chronic diseases, and premature death and should be screened for and managed, new research suggested. “There is nearly irrefutable evidence on the effectiveness of regular physical activity in the primary and secondary prevention of several chronic diseases, including diabetes,” Louis Carr, PhD, Iowa Bioscience Innovation Facility, Iowa … Read more